4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-007483
President and CEO sold 18,334 shares at an average $18.72 ($343,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-02-01 | Sale | −6,050 | $18.65 | $112,833 | 2,646,588 | I |
| Watts Ryan J. President and CEO | 2019-02-04 | Sale | −3,200 | $18.49 | $59,168 | 2,643,388 | I |
| Watts Ryan J. President and CEO | 2019-02-04 | Sale | −854 | $19.12 | $16,328 | 2,642,534 | I |
| Watts Ryan J. President and CEO | 2019-02-05 | Sale | −8,230 | $18.83 | $154,971 | 2,634,304 | I |
| Open-market sales · 18,334 sh · avg $18.72 · $343,300 | |||||||
Loading xslF345X03/doc4.xml…